Peter Zerhouni

Biography

Zerhouni is the CEO of InDex Pharmaceuticals Holding AB since 2016 and of InDex Pharmaceuticals AB and InDex Diagnostics AB since 2015. Zerhouni has extensive experience in developing life science companies from both a scientific and commercial perspective. Peter joined InDex from the listed company Diamyd Medical AB where he was CEO since 2011 and where he also has been head of Business Development. He was a driving force behind one of the largest biotech out-licensing deals in Sweden in 2010. Zerhouni has previously held various positions at ING Bank in Brussels and Amsterdam. He holds a Master of Science degree in Biology as well as a Business of Science degree in Business Administration from Lund University (part of the course work was completed at University of California at Berkely).

Research Interest

.